SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRARI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 46.574
AS - Asia 19.949
EU - Europa 13.660
SA - Sud America 3.649
AF - Africa 317
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 22
AN - Antartide 2
Totale 84.230
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 45.878
SG - Singapore 8.143
CN - Cina 5.667
IT - Italia 3.690
BR - Brasile 3.072
UA - Ucraina 2.485
HK - Hong Kong 2.112
DE - Germania 2.065
TR - Turchia 1.525
GB - Regno Unito 1.345
VN - Vietnam 1.059
FI - Finlandia 807
SE - Svezia 763
RU - Federazione Russa 654
PL - Polonia 620
MX - Messico 353
FR - Francia 322
ID - Indonesia 305
CA - Canada 265
IN - India 257
AR - Argentina 220
NL - Olanda 164
BD - Bangladesh 153
JP - Giappone 135
ZA - Sudafrica 130
ES - Italia 126
BE - Belgio 119
EC - Ecuador 109
IQ - Iraq 104
AT - Austria 100
CO - Colombia 71
CZ - Repubblica Ceca 63
LT - Lituania 58
PK - Pakistan 58
VE - Venezuela 50
IE - Irlanda 47
CH - Svizzera 45
EG - Egitto 44
UZ - Uzbekistan 43
KR - Corea 42
AU - Australia 41
PY - Paraguay 40
CL - Cile 39
MA - Marocco 31
JO - Giordania 26
AE - Emirati Arabi Uniti 24
IR - Iran 24
KE - Kenya 24
SA - Arabia Saudita 24
TN - Tunisia 24
PE - Perù 23
TW - Taiwan 22
LK - Sri Lanka 21
MY - Malesia 20
AL - Albania 19
GE - Georgia 19
BG - Bulgaria 18
UY - Uruguay 18
IL - Israele 17
RO - Romania 17
DZ - Algeria 15
NZ - Nuova Zelanda 15
RS - Serbia 15
HR - Croazia 14
PH - Filippine 14
TH - Thailandia 14
AZ - Azerbaigian 13
JM - Giamaica 13
PT - Portogallo 13
EU - Europa 12
GR - Grecia 12
KZ - Kazakistan 12
OM - Oman 12
HU - Ungheria 11
LB - Libano 11
TT - Trinidad e Tobago 11
KG - Kirghizistan 10
PS - Palestinian Territory 10
SN - Senegal 10
NO - Norvegia 9
DK - Danimarca 8
PA - Panama 8
XK - ???statistics.table.value.countryCode.XK??? 8
BH - Bahrain 7
BY - Bielorussia 7
CI - Costa d'Avorio 7
GT - Guatemala 7
MD - Moldavia 7
NP - Nepal 7
SK - Slovacchia (Repubblica Slovacca) 7
BA - Bosnia-Erzegovina 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
NI - Nicaragua 6
SI - Slovenia 6
SV - El Salvador 6
CR - Costa Rica 5
HN - Honduras 5
KH - Cambogia 5
MK - Macedonia 5
Totale 84.134
Salva come PNG Salva come JPEG
Città #
Fairfield 5.337
Woodbridge 5.001
Singapore 4.365
Ashburn 4.212
Houston 3.179
Jacksonville 2.708
Chandler 2.389
Seattle 2.119
Ann Arbor 2.106
Hong Kong 2.094
Wilmington 1.878
Cambridge 1.776
Santa Clara 1.676
Dallas 1.643
Beijing 1.625
Izmir 955
Nanjing 871
Princeton 751
Warsaw 586
Los Angeles 525
San Diego 477
New York 460
Munich 431
Boardman 422
Ferrara 405
Milan 368
Ho Chi Minh City 357
São Paulo 286
Shanghai 270
Shenyang 262
Mexico City 248
Nanchang 245
Jakarta 228
Moscow 217
Hanoi 197
Chicago 180
London 177
Rome 177
Hefei 169
Tianjin 163
Helsinki 159
Falls Church 155
Changsha 154
Hebei 147
Jiaxing 147
Turku 139
Bremen 134
Redwood City 132
San Mateo 121
Mountain View 119
Dong Ket 118
Tokyo 116
Brussels 111
Rio de Janeiro 108
Addison 107
Brooklyn 104
The Dalles 103
Buffalo 102
Jinan 101
Bologna 95
Zhengzhou 92
Nuremberg 83
Norwalk 82
Dearborn 80
Phoenix 77
Chennai 76
Falkenstein 75
Montreal 74
Naples 71
San Francisco 70
Johannesburg 69
Columbus 68
Stockholm 68
Ningbo 65
Belo Horizonte 64
Boston 64
Guangzhou 64
Council Bluffs 63
Verona 63
Kunming 62
Washington 62
Toronto 57
Atlanta 56
Orem 54
Des Moines 53
Manchester 53
Denver 52
Philadelphia 52
Curitiba 51
Frankfurt am Main 51
Orange 51
Brasília 50
Poplar 48
Taizhou 48
Napoli 43
Ankara 42
Haiphong 42
Tashkent 41
Porto Alegre 40
Quito 40
Totale 56.423
Salva come PNG Salva come JPEG
Nome #
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI 1.800
1,3,8-Triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury. 1.035
Il lungo cammino degli inibitori dell'enzima di conversione dell'angiotensina nella lotta per le malattie cardiovascolari 428
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 395
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 371
Valutazione ecocardiografica dell'insufficienza mitralica nella prospettiva della riparazione valvolare 341
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 334
Left ventricular ejection fraction and heart failure: an indissoluble marriage? 333
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 319
The Notch pathway: a novel therapeutic target for cardiovascular diseases? 306
Scompenso cardiaco con frazione di eiezione intermedia. Alla ricerca della Terra di Mezzo? 302
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 297
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 264
Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: A pilot study 261
Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis 260
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 247
Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in Spain 241
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) 237
Polar plot maps by parametric strain echocardiography allow accurate evaluation of non-viable transmural scar tissue in ischaemic heart disease 236
17β-Estradiol Enhances Signalling Mediated by VEGF-A-Delta-Like Ligand 4-Notch1 Axis in Human Endothelial Cells 233
2014 ESC guidelines on the diagnosis and treatment of aortic diseases 231
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 231
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 229
CANCER THERAPY-INDUCED CARDIOTOXICITY: ROLE OF ULTRASOUND DEFORMATION IMAGING AS AN AID TO EARLY DIAGNOSIS 227
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 227
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 224
Cardiac resynchronization therapy guided by multimodality cardiac imaging 223
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 222
Poor response to clopidogrel: current and future options for its management 222
2013 ESC guidelines on the management of stable coronary artery disease 215
The role of Notch pathway in cardiovascular diseases. 215
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma 214
Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients 213
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 211
2013 ESH/ESC Guidelines for the management of arterial hypertension 211
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 208
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 206
null 206
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 204
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 203
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 201
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 200
KRIT1 deficiency promotes aortic endothelial dysfunction 200
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 199
Uric acid and coronary artery disease: An elusive link deserving further attention 199
A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of Genetics 199
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) 196
Abnormalities of Left Ventricular Function in Asymptomatic Patients with Systemic Sclerosis Using Doppler Measures of Myocardial Strain 195
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 194
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 194
Heart failure with preserved ejection fraction: uncertainties and dilemmas 193
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 192
Left Ventricular Lead Position Guided by Parametric Strain Echocardiography Improves Response to Cardiac Resynchronization Therapy 190
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion 189
Current views on anthracycline cardiotoxicity 188
Attualità e nuove prospettive in tema di cardiogenetica 187
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 186
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 185
Can we improve myocardial protection during ischaemic injury? 185
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 185
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 184
Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome 184
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 184
181 QUESTIONS & ANSWERS IN HEART FAILURE Heart failure 181 Questions & Answers. 183
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 182
The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors 181
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 178
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 177
Aortic valve stenosis and mitochondrial dysfunctions: Clinical and molecular perspectives 177
Angina and left ventricular dysfunction: can we "reduce' it? 177
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 177
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 176
Current role of echocardiography in cardiac resynchronization therapy 176
Remote monitoring of implantable devices: Should we continue to ignore it? 174
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 174
The in vitro effects of verbascoside on human platelet aggregation 173
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: An analysis from the SIGNIFY study 173
Anti-anginal drugs: Systematic review and clinical implications 173
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 172
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 172
Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: Analysis of the CLARIFY registry 171
Cardiovascular complications of radiation therapy for thoracic malignancies: The role for non-invasive imaging for detection of cardiovascular disease 171
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress 171
Prolonged propionyl-L-carnitine pre-treatment of rabbit: Biochemical, hemodynamic and electrophysiological effects on myocardium 170
2013 ESCGuidelines on cardiac pacing and cardiac resynchronization therapy 170
Reperfusion Damage - A Story of Success, Failure, and Hope 170
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction 169
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 169
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 169
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 168
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 168
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 168
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions 168
99mTc-sestamibi gted -Spect evaluation of post stress left ventricular ejection fraction and volumes in hypertensive patients exhibiting a normal scintigraphic perfusion pattern 167
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 167
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 165
Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention 164
Impact of a recent hospitalization on treatment and prognosis of ST-segment elevation myocardial infarction 163
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 163
Individualized angiotensin-converting enzyme (ACE)-inhibitor therapy in stable coronary artery disease based on clinical and pharmacogenetic determinants: The PERindopril GENEtic (PERGENE) risk model 162
Totale 23.339
Salva come PNG Salva come JPEG
Categoria #
all - tutte 408.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.721
Totale 414.029
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.143 0 0 0 0 0 913 316 1.061 254 1.119 996 484
2021/20227.070 323 777 577 273 413 357 359 366 296 505 753 2.071
2022/20236.078 715 190 226 668 982 900 219 634 840 60 397 247
2023/20243.481 359 433 210 120 238 490 152 206 77 160 153 883
2024/202512.621 303 307 1.107 466 1.429 1.036 462 840 2.357 1.378 1.541 1.395
2025/202618.864 3.125 1.753 4.140 4.575 4.716 555 0 0 0 0 0 0
Totale 85.219